Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Junshi Biosciences
Biotech
Coherus axes TIGIT program 2 years after making $35M bet
The decision follows an analysis of data from a trial of the TIGIT candidate and results in rival programs.
Nick Paul Taylor
Jan 10, 2024 7:50am
Junshi's Lynparza rival hits mark in ovarian cancer phase 3
Apr 12, 2023 5:30am
Junshi data tee up challenge to Amgen, Sanofi in growth market
Feb 28, 2023 2:00am
I-Mab, Junshi's cancer combo worked best as first-line treatment
May 26, 2022 5:00pm
Junshi tees up China filing for PD-1 med after throat cancer win
Sep 29, 2020 9:50am
